These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15016750)

  • 1. Incidence and management of malignant digestive endocrine tumours in a well defined French population.
    Lepage C; Bouvier AM; Phelip JM; Hatem C; Vernet C; Faivre J
    Gut; 2004 Apr; 53(4):549-53. PubMed ID: 15016750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and management of primary malignant small bowel cancers: a well-defined French population study.
    Lepage C; Bouvier AM; Manfredi S; Dancourt V; Faivre J
    Am J Gastroenterol; 2006 Dec; 101(12):2826-32. PubMed ID: 17026561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
    Lepage C; Rachet B; Coleman MP
    Gastroenterology; 2007 Mar; 132(3):899-904. PubMed ID: 17383419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digestive neuroendocrine tumours: diagnosis and treatment in Italy. A survey by the Oncology Study Section of the Italian Society of Gastroenterology (SIGE).
    Corleto VD; Panzuto F; Falconi M; Cannizzaro R; Angeletti S; Moretti A; Delle Fave G; Farinati F;
    Dig Liver Dis; 2001 Apr; 33(3):217-21. PubMed ID: 11407665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and management of cancer of the ampulla of Vater.
    Rostain F; Hamza S; Drouillard A; Faivre J; Bouvier AM; Lepage C
    World J Gastroenterol; 2014 Aug; 20(29):10144-50. PubMed ID: 25110442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine tumours: epidemiology of malignant digestive neuroendocrine tumours.
    Lepage C; Bouvier AM; Faivre J
    Eur J Endocrinol; 2013 Apr; 168(4):R77-83. PubMed ID: 23349330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer of the ampulla of Vater: results of a 20-year population-based study.
    Benhamiche AM; Jouve JL; Manfredi S; Prost P; Isambert N; Faivre J
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):75-9. PubMed ID: 10656214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the management and survival of digestive tract cancers among patients aged over 80 years.
    Bouvier AM; Launoy G; Lepage C; Faivre J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):233-41. PubMed ID: 16091061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence and management of esophageal adenocarcinoma in a well-defined population.
    Lepage C; Bouvier AM; Manfredi S; Coatmeur O; Cheynel N; Faivre J
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1258-63. PubMed ID: 16518284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Gastric Cancer: Trends in Incidence, Management, and Survival in a Well-Defined French Population.
    Chapelle N; Bouvier AM; Manfredi S; Drouillard A; Lepage C; Faivre J; Jooste V
    Ann Surg Oncol; 2016 Oct; 23(11):3677-3683. PubMed ID: 27216743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the incidence and management of biliary tract cancer: a French population-based study.
    Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
    J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Digestive cancers in France. Geographic distribution and estimation of national incidence].
    Faivre J; Grosclaude P; Launoy G; Arveux P; Raverdy N; Menegoz F; Pienkowski P; Schaffer P; Daures JP; De Vathaire F
    Gastroenterol Clin Biol; 1997; 21(3):174-80. PubMed ID: 9161491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence and management of gallbladder carcinoma: a population-based study in France.
    Manfredi S; Benhamiche AM; Isambert N; Prost P; Jouve JL; Faivre J
    Cancer; 2000 Aug; 89(4):757-62. PubMed ID: 10951337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Engholm G; Storm HH; Tryggvadóttir L; Gislum M; Hakulinen T; Bray F
    Acta Oncol; 2010 Jun; 49(5):578-607. PubMed ID: 20491524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence of digestive cancers in France.
    Lepage C; Remontet L; Launoy G; Trétarre B; Grosclaude P; Colonna M; Velten M; Buemi A; Danzon A; Molinie F; Maarouf N; Bossard N; Bouvier AM; Faivre J;
    Eur J Cancer Prev; 2008 Feb; 17(1):13-7. PubMed ID: 18090905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the incidence of digestive cancers in France between 1980 and 2005 and projections for the year 2010.
    Jooste V; Remontet L; Colonna M; Belot A; Launoy G; Binder F; Faivre J; Bouvier AM
    Eur J Cancer Prev; 2011 Sep; 20(5):375-80. PubMed ID: 21478752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).
    de Mestier L; Lepage C; Baudin E; Coriat R; Courbon F; Couvelard A; Do Cao C; Frampas E; Gaujoux S; Gincul R; Goudet P; Lombard-Bohas C; Poncet G; Smith D; Ruszniewski P; Lecomte T; Bouché O; Walter T; Cadiot G;
    Dig Liver Dis; 2020 May; 52(5):473-492. PubMed ID: 32234416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.